XML 12 R3.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Interim Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Jul. 31, 2025
Jul. 31, 2024
Jul. 31, 2025
Jul. 31, 2024
Operating expenses        
General and administrative $ 684,716 $ 1,125,365 $ 2,574,576 $ 3,262,427
Research and development, net 723,048 345,883 1,636,343 896,317
Total operating expenses 1,407,764 1,471,248 4,210,919 4,158,744
Finance income (expenses)        
Changes in fair value of derivative warrant liabilities (Note 5) 139,563 (643,225) 1,319,081 (83,080)
Changes in fair value of short-term investments (Note 3) (63,602) (292,390) (7,612)
Foreign exchange gain (loss) 3,068 (5,380) 864 (2,709)
Other finance expenses (9,192) (61,408) (25,775) (30,379)
Interest income on deposits 32,593 146,432 108,249 209,934
Other expenses (16,498) (16,498)
Total finance income (expenses) 102,430 (580,079) 1,110,029 69,656
Loss before taxes (1,305,334) (2,051,327) (3,100,890) (4,089,088)
Tax expenses (8,258) (42,590) (68,251) (280,846)
Net Loss and Comprehensive loss $ (1,313,592) $ (2,093,917) $ (3,169,141) $ (4,369,934)
Loss per share, basic (in Dollars per share) $ (0.25) $ (0.59) $ (0.64) $ (1.58)
Loss per share, diluted (in Dollars per share) $ (0.25) $ (0.59) $ (0.64) $ (1.58)
Weighted average number of shares for the purposes of basic loss per share (in Shares) 5,342,211 3,559,860 4,954,577 2,773,384
Weighted average number of shares for the purposes of diluted loss per share (in Shares) 5,342,211 3,559,860 4,954,577 2,773,384